RxDoctor Payments Data

Savannah Hodges, NP

Nurse Practitioner · Mount Airy, NCNPI 1174162473

Payments from drug & device makers

$1,814in general payments, 2019–2025

Across 115 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$514
  • Novo Nordisk$266
  • Lilly USA, LLC$165
  • Astellas Pharma US Inc$154
  • Otsuka America Pharmaceutical, Inc.$141
  • AstraZeneca$140
  • plus $433 from 12 others

What the payments were for

  • Food & beverage$1,71695%
  • Education$995%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,814 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$164
Medicare patients
11
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$59,991
EliquisApixaban16$20,482
Breztri AerosphereBudesonide/Glycopyr/Formoterol29$18,730
JardianceEmpagliflozin18$15,791
MounjaroTirzepatide12$13,283
JanumetSitagliptin Phos/Metformin Hcl14$7,927
SymbicortBudesonide/Formoterol Fumarate20$5,237
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,374
Ventolin HfaAlbuterol Sulfate15$983
Albuterol Sulfate HfaAlbuterol Sulfate39$973
Atorvastatin Calcium144$862
Celecoxib66$773
Humulin 70-30Insulin Nph Hum/Reg Insulin Hm16$729
Gabapentin88$642
Hydroxyzine Hcl35$490

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$266$59,99159 claims
AstraZenecaBreztri Aerosphere, Symbicort$140$23,96649 claims
PfizerEliquis$18$20,48216 claims
Boehringer IngelheimJardiance$70$15,79118 claims
Lilly USA, LLCMounjaro, Humulin 70-30$165$14,01228 claims
MerckJanumet$14$7,92714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Mount Airy

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →